BEIJING, May 11, 2026 (GLOBE NEWSWIRE) — Haoxi Health Technology Ltd (NASDAQ: HAO) (“Haoxi” or the “Company”) today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of approximately $6.5 million of the Company’s securities, including 9,000,000 Class A ordinary shares, par value $0.0025 per share (the “Shares”) and 16,999,998 pre-funded warrants, at a purchase price of $0.25 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.0026 per share. Each pre-funded warrant is exercisable to purchase 10.355 Shares. The aggregate gross proceeds to the Company of this offering are expected to be approximately $6.5 million, before deducting placement agent...

Delivers record total revenue and AVISE(R) CTD average selling price CARLSBAD, Calif., May 11, 2026 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2026, and recent corporate updates.    Three Months Ended March 31,      2026     2025Unaudited. In thousands, except ASP data.    Revenue   $ 17,306     $ 15,498  Gross margin     59.0 %     58.9 %Operating expenses   $ 13,619     $ 12,488  Operating loss   $ (3,414 )   $ (3,365 )Net loss   $ (3,967 )   $ (3,752 )Adjusted EBITDA   $ (2,160 )   $ (2,508 )Trailing-twelve-month average selling price (ASP)   $ 444     $ 419  Cash and cash equivalents   $ 21,513     $ 11,194                   First Quarter 2026 Highlights:Achieved record...

OTC: BCBC advances financial reporting and governance initiatives as part of planned transition toward OTCQB and Nasdaq eligibility LAS VEGAS, May 11, 2026 (GLOBE NEWSWIRE) — Bitcoin Bancorp, Inc. (OTC: BCBC) (“Bitcoin Bancorp” or the “Company”), the holder of foundational patents for Bitcoin ATMs, and one of only three publicly traded Bitcoin ATM network owner/operators, today announced that the Company has engaged a PCAOB-registered independent public accounting firm to audit the Company’s financial statements. The engagement represents a significant step in the Company’s efforts to strengthen corporate governance, improve financial transparency, and advance its preparation for potential uplisting to higher-tier public markets, including the OTCQB and ultimately the Nasdaq Stock Market. The audits will be conducted in accordance...

Expands life sciences marketers’ reach at the validated point of care, enabling DSPs to directly integrate with OptimizeRx’s trusted EHR network for the first time WALTHAM, Mass., May 11, 2026 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare providers (HCPs) and patients at the most important decision points, today announced the launch of a new programmatic connection point between OptimizeRx’s proprietary EHR network and DSPs, enabling media buyers to activate scalable, point of care campaigns within their existing programmatic workflows. This launch also opens up new access for OptimizeRx to the programmatic market, estimated at 90% of the total U.S. digital display ad spend across all industries. Bridging...

Presented positive Phase 3 HAELO topline clinical data for lonvo-z in HAE; initiated rolling BLA submission; anticipate U.S. launch in first half of 2027 Recently resumed patient screening in MAGNITUDE and MAGNITUDE-2 Phase 3 clinical trials of nex-z in ATTR-CM and ATTRv-PN, respectively Including proceeds from underwritten public offering in April, existing cash resources expected to fund operations at least into 2028CAMBRIDGE, Mass., May 11, 2026 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today reported business updates and financial results for the first quarter ended March 31, 2026. “It has been a remarkable start to 2026 for Intellia,” said John Leonard, M.D., Intellia President...

Net revenue in Q1 2026 increased by 40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada1 Ninth consecutive quarter of record net revenue in Israel, where PEACE NATURALS® continues to be the number one cannabis brand2 Industry-leading balance sheet with $822 million in total cash and cash equivalents TORONTO, May 11, 2026 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2026 first quarter business results. “Cronos delivered record net revenue and gross profit in the first quarter, as we continue to execute against our borderless products strategy and as additional supply from the expansion at Cronos GrowCo fuels our next phase of growth. Cronos Israel delivered another record quarter,...

DALLAS, May 11, 2026 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today issued a statement regarding the conviction of the Company’s former Chairman and CEO, Brad Heppner, by a federal jury in the United States District Court for the Southern District of New York (“SNDY”) on charges of securities fraud, wire fraud, conspiracy to commit securities fraud and wire fraud, and false statements to auditors in connection with a scheme to defraud GWG Holdings, Inc. As established at trial, Mr. Heppner acted solely on behalf of his family office to perpetrate this scheme through a shell company he controlled. See here for SDNY’s press release announcing the verdict. As...